Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ree-Trakt is a medicated gingival retraction cord used in restorative dentistry to facilitate accurate impressions by providing temporary displacement of the gingival margin and controlling local capillary bleeding. The cord is impregnated with epinephrine, a sympathomimetic amine that acts as a potent vasoconstrictor. Upon contact with the moist gingival tissues, epinephrine is released and stimulates alpha-adrenergic receptors in the local vasculature, leading to localized vasoconstriction. This physiological response results in tissue shrinkage and hemostasis, creating a clear and dry operative field necessary for high-precision dental procedures such as crown and bridge preparations. Ree-Trakt is available in various thicknesses and is manufactured by Pascal International.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ree-Trakt.